JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB280048

Human CD167a/DDR1 knockout MCF7 cell line

Be the first to review this product! Submit a review

|

(0 Publication)

DDR1 KO cell line available to order. KO validated by Western blot. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 59 bp Deletion in Exon 5. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
3 Images
Western blot - Human CD167a/DDR1 knockout MCF7 cell line (AB280048)
  • WB

Lab

Western blot - Human CD167a/DDR1 knockout MCF7 cell line (AB280048)

Western blot : Anti-DDR1 antibody [EPR24783-7] (ab288675) staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab288675 was shown to bind specifically to DDR1. A band was observed at 100-125 kDa in wild-type HeLa cell lysates with no signal observed at this size in DDR1 knockout cell line ab280048 (knockout cell lysate ab280107). To generate this image, wild-type and DDR1 knockout HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-CD167a/DDR1 antibody [EPR24783-7] (<a href='/en-us/products/primary-antibodies/cd167a-ddr1-antibody-epr24783-7-ab288675'>ab288675</a>) at 1/1000 dilution

Lane 1:

HeLa cell lysate at 20 µg

Lane 2:

NIH/3T3 cell lysate at 20 µg

Lane 3:

T-47D cell lysate at 20 µg

Lane 4:

Human Brain cell lysate at 20 µg

Lane 5:

Human Liver cell lysate at 20 µg

Lane 6:

Mouse Brain cell lysate at 20 µg

Lane 7:

Mouse Liver cell lysate at 20 µg

Lane 8:

Wild-type MCF7 Serum Starved (24 h) Vehicle Control Collagen I (0 ug/mL, 16 h) ab288242 cell lysate at 20 µg

Lane 9:

Wild-type MCF7 Serum Starved (24 h) Treated Collagen I (25 ug/mL, 16 h) ab288241 cell lysate at 20 µg

Lane 10:

DDR1 knockout MCF7 Serum Starved (24 h) Vehicle Control Collagen I (0 ug/mL, 16 h) ab288240 cell lysate at 20 µg

Lane 11:

DDR1 knockout MCF7 Serum Starved (24 h) Treated Collagen I (25 ug/mL, 16 h) ab288238 cell lysate at 20 µg

Secondary

All lanes:

Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Predicted band size: 125 kDa

Observed band size: 100 kDa,125 kDa

false

Western blot - Human CD167a/DDR1 knockout MCF7 cell line (AB280048)
  • WB

Lab

Western blot - Human CD167a/DDR1 knockout MCF7 cell line (AB280048)

False colour image of Western blot : Anti-DDR1 antibody staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, the antibody was shown to bind specifically to DDR1. A band was observed at 105 kDa in treated wild-type MCF7 cell lysates with no signal observed at this size in DDR1 knockout cell line ab280048 (knockout cell lysate ab280107). To generate this image, wild-type and DDR1 knockout MCF7 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

Lane 1:

Human wild-type MCF7 cell lysate -&nbsp;Serum starved collagen I treated (ab288241) at 20 µg

Lane 2:

Human DDR1 (MCK10/NEP) knockout MCF7 cell lysate - Serum starved and collagen I treated (ab288238) at 20 µg

Lane 2:

Western blot - Human CD167a/DDR1 knockout MCF7 cell line (ab280048)

Lane 3:

Human wild-type MCF7 cell lysate -&nbsp;Serum starved control for collagen I (ab288242) at 20 µg

Lane 4:

Human DDR1 (MCK10/NEP) knockout MCF7 cell lysate -Serum starved and control for collagen I (ab288240) at 20 µg

Lane 5:

A549 cell lysate at 20 µg

Lane 6:

HeLa cell lysate at 20 µg

false

Sanger Sequencing - Human CD167a/DDR1 knockout MCF7 cell line (AB280048)
  • Sanger seq

Lab

Sanger Sequencing - Human CD167a/DDR1 knockout MCF7 cell line (AB280048)

59 bp Deletion in Exon 5

Key facts

Cell type

MCF7

Species or organism

Human

Tissue

Breast

Form

Liquid

form

Knockout validation

Sanger Sequencing,Western blot

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 59 bp Deletion in Exon 5

Disease

Adenocarcinoma

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab280048-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab277916 Human wild-type MCF7 cell line", "number":"AB280048-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab280048 Human CD167a/DDR1 knockout MCF7 cell line", "number":"AB280048-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab280048-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab280048 Human CD167a/DDR1 knockout MCF7 cell line", "number":"AB280048-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
DDR1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing, Western blot
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • Slow to trypsinise.
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 5-7x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

MEM + 10% FBS + 0.01 mg/ml bovine insulin

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CD167a also known as DDR1 (Discoidin Domain Receptor 1) is a receptor tyrosine kinase with a molecular mass of approximately 101 kDa. This protein is expressed widely in various tissues including the thyroid lung kidney and mammary gland. It becomes activated upon collagen binding leading to the regulation of cell adhesion proliferation and extracellular matrix remodeling. The DDR1 protein plays a mechanistic role in responding to unique collagen-rich environments within the body.
Biological function summary

CD167a/DDR1 modulates interactions between cells and their surrounding matrix. It is involved in a complex with collagen mediating signal transduction processes. This interaction is important for cellular biophysical responses driving processes like cell migration and differentiation. In marmoset thyroid tissue DDR1 helps maintain structural integrity and regulates cellular activities important for normal thyroid function.

Pathways

CD167a/DDR1 participates in key signaling pathways including those related to cell adhesion and extracellular matrix remodeling. Specifically it operates within the MAPK/ERK pathway influencing cell cycle dynamics and responses to stress signals. DDR1 also interacts with proteins like SHC and Ras enabling communication between the cell surface and intracellular targets necessary for growth and adaptation.

Mutations or irregular expression of CD167a/DDR1 have implications in cancer and fibrotic diseases. Overexpression or aberration of DDR1 can contribute to tumorigenesis facilitating tumor cell invasion and metastasis. In fibrotic conditions altered DDR1 activity can disrupt normal matrix remodeling linking it to proteins such as collagen I and III which play major roles in these disorders. Understanding DDR1's role offers potential for therapeutic interventions in targeting related pathological conditions.

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com